GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » H. Lundbeck AS (OCSE:HLUN A) » Definitions » Inventories, Finished Goods

H. Lundbeck AS (OCSE:HLUN A) Inventories, Finished Goods : kr1,451 Mil (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is H. Lundbeck AS Inventories, Finished Goods?

H. Lundbeck AS's quarterly finished goods stayed the same from Jun. 2024 (kr0 Mil) to Sep. 2024 (kr0 Mil) but then increased from Sep. 2024 (kr0 Mil) to Dec. 2024 (kr1,451 Mil).

H. Lundbeck AS's annual finished goods increased from Dec. 2022 (kr1,557 Mil) to Dec. 2023 (kr1,633 Mil) but then declined from Dec. 2023 (kr1,633 Mil) to Dec. 2024 (kr1,451 Mil).

H. Lundbeck AS Inventories, Finished Goods Historical Data

The historical data trend for H. Lundbeck AS's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

H. Lundbeck AS Inventories, Finished Goods Chart

H. Lundbeck AS Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 802.00 1,034.00 1,557.00 1,633.00 1,451.00

H. Lundbeck AS Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,633.00 - - - 1,451.00

H. Lundbeck AS Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

H. Lundbeck AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » H. Lundbeck AS (OCSE:HLUN A) » Definitions » Inventories, Finished Goods
Comparable Companies
OCSE:STENO ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA ITCI SZSE:000538 UTHR BOM:500087 TSE:4507 SHSE:688506 NSE:TORNTPHARM BOM:543904 NBIX
Traded in Other Exchanges
HLBBF:USA HLUBF:USA 0ABR:UK 0ND5:UK HLUN B:Denmark LDBA:Germany LUNB:Austria LUNA:Austria
Address
Ottiliavej 9, Valby, DNK, 2500
Website
https://www.lundbeck.com
Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system drugs including antidepressants, antipsychotics, and antiepileptic products. The company's portfolio includes Abilify Maintena and Rexulti for psychosis, Brintellix/Trintellix for depression, Northera for Parkinson's disease symptoms, Sabril and Onfi for seizures, and Vyepti for migraine prevention. Most of the company's sales are derived in North America, followed by Asia and Europe.

H. Lundbeck AS Headlines

No Headlines